Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor ImmunityXian-Yang Li, Mark J. Smyth, Achim K. Moesta et al.|Cancer Discovery|2019Cited by 269
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaLuiza Martins Nascentes Melo, Iris Helfrich, Juliane Klein et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 31
Meeting Report: 47th Annual Meeting of the “Arbeitsgemeinschaft Dermatologische Forschung”Georg Stary, Timo Buhl, Mario Fabri et al.|Experimental Dermatology|2022Cited by 0